Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P (2010) OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009
Concomitant ICV administration of GLP- 1 and GIP significantly reduced food intake, body weight, and alcohol consumption
Some people tolerate tirzepatide with no sulfur burps but cannot handle semaglutide, and vice versa
About Fridays Health Fridays is a telehealth platform that connects members with board-certified physicians and licensed nurse practitioners who evaluate eligibility and prescribe GLP-1 medications when appropriate